Stockwell Elastomerics to invest more than $8M in expansion
Stockwell Elastomerics is spending more than $8 million to expand its Philadelphia manufacturing footprint, add equipment and hire technical staff. The move is meant to boost capacity for aerospace, defense, medical, semiconductor and electronics customers as production begins at a new facility in 2027.
Why it matters: - Stockwell Elastomerics is adding space, equipment and engineering talent to handle rising demand for custom silicone and elastomeric parts. - The expansion is aimed at faster prototyping, higher production capacity and better support for customers in regulated and technology-driven industries. - The investment also strengthens the company’s ability to maintain quality and scale production without sacrificing response times.
What happened: - Stockwell Elastomerics announced more than $8 million in investments across facilities, manufacturing capacity and technical staff. - The Philadelphia-based manufacturer acquired an adjacent 38,000-square-foot building near its corporate campus. - The new facility will lift the Stockwell campus to more than 100,000 square feet. - The company expects to complete planning, infrastructure work and renovations during 2026. - Manufacturing operations at the new site are expected to begin in 2027.
The details: - Stockwell Elastomerics added three new compression molding presses. - The company also added a new Liquid Injection Molding press. - Additional manufacturing infrastructure is in place to support higher production volumes and shorter project timelines. - The equipment expands capacity for prototype and production work across silicone, fluorosilicone, conductive elastomer and specialty engineered material applications. - The new compression molding presses increase output for custom-molded elastomer components. - The LIM press is meant to support highly repeatable, precision-molded silicone parts with tight tolerances and consistent material performance. - Fifteen recent hires have expanded the applications engineering, customer service and quality teams. - The company maintained its ISO 9001 and AS9100 certifications. - Stockwell Elastomerics is also growing investments in sales and engineering, supplier and manufacturing partnerships, research and development, compliance, automation and prototype-to-production capabilities. - The company serves aerospace, defense, medical devices, semiconductor manufacturing, electronics, instrumentation, robotics and other advanced technology markets. - Stockwell Elastomerics is AS9100-certified and ITAR-registered. - The company provides rapid prototyping and production manufacturing services for sealing, cushioning, thermal management and electromagnetic interference shielding applications. - More information is available on the company’s website.
Between the lines: - The expansion suggests Stockwell Elastomerics is preparing for larger and more complex customer programs. - Adding both floor space and specialized molding equipment points to a push for more in-house control over speed, quality and production flexibility. - The hiring spree and quality investment indicate the company is trying to scale without weakening the consultative engineering model that supports custom work.
What's next: - Stockwell Elastomerics will finish facility planning, infrastructure upgrades and renovations during 2026. - Production at the new Philadelphia facility is expected to start in 2027. - The company is expected to keep investing in technology, equipment and talent as customer demand grows.
The bottom line: - Stockwell Elastomerics is betting that a bigger plant, more automation and more engineering depth will help it win and serve more high-spec manufacturing work.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Healthcare Press Releases
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.